Hitachi, Ltd. Company Profile

19:02 EDT 22nd March 2019 | BioPortfolio

Hitachi, Ltd., (NYSE: HIT / TSE: 6501), headquartered in Tokyo, Japan, is a leading global electronics company with approximately 360,000 employees worldwide. Fiscal 2009 (ended March 31, 2010) consolidated revenues totaled 8,968 billion yen ($96.4 billion). Hitachi will focus more than ever on the Social Innovation Business, which includes information and telecommunication systems, power systems, environmental, industrial and transportation systems, and social and urban systems, as well as the sophisticated materials and key devices that support them. For more information on Hitachi, please visit the company's website at

News Articles [26 Associated News Articles listed on BioPortfolio]

Hitachi buys all Acpeth Biopharma shares

Apceth Biopharma now becomes Hitachi's new European hub for cell therapy

Hitachi Chemical Acquires apceth Biopharma

Through this deal, Hitachi Chemical will acquire two state-of-the-art GMP/BSL2 production facilities including 600 m2 of cleanroom area

Hitachi Chemical buys cell therapy-focused CDMO in Germany

The deal will add two manufacturing sites in Munich to Hitachi's portfolio, which already includes sites in the U.S. and Japan.

Hitachi's First Dedicated Compact Proton Therapy System to be Supplied to Tokushukai Medical Group

Hitachi, Ltd. (TSE: 6501, “Hitachi”) announced today that it has received an order for the compact proton therapy system from Tokushukai Medical Group, and the system will be installed at Shonan K...

Hitachi Acquires Germany’s Apceth Biopharma

Japan’s Hitachi Chemical is buying Apceth Biopharma, a German contract manufacturer of complex cell-based and gene-therapy products, for €75.5 million. The acquisition is expected to close ...

Hitachi Medical introduces third generation of non-invasive intracardiac blood flow visualization technology

The company unveiled the next level of intelligent Vector Flow Mapping (iVFM) at EuroEcho Imaging 2018 in Milan, Italy. Hitachi claims that the third generation the technology offers unique infor...

Hitachi Chemical to acquire apceth Biopharma

This acquisition is expected to close in April 2019. Founded 2007, apceth is a pioneer in cell and gene therapy and has developed into a leading European contract The post Hitachi Chemical to acquire...

Hitachi is set to take over cell and gene therapy #CDMO apceth Biopharma to get a foothold in Europe @HitachiGlobal #CellTherapy #GeneTherapy

Hitachi is set to take over cell and gene therapy #CDMO apceth Biopharma to get a foothold in Europe @HitachiGlobal #CellTherapy #GeneTherapy

Drugs and Medications [0 Results]


PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

A population-based cohort study to evaluate the effectiveness of lung cancer screening using low-dose CT in Hitachi city, Japan.

To evaluate the effectiveness of lung cancer screening using low-dose computed tomography for the general population, we conducted a retrospective cohort study of screening for participants among Hita...

Standardization of measurement procedures for serum uric acid: 8-year experience from Category 1 EQA program results in China.

Background Serum uric acid is a critical clinical indicator, and results without equivalence among laboratories cause troubles for disease diagnosis and patient management. External quality assessment...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Emotion Study -- A Neurofeedback Approach

This study will determine whether brain activity can be modified and improves performance on a task by showing participants live 'video feed' of their brains on advanced imaging technology...

Evaluation of a Dashboard for Diabetes Care Integrated With the Electronic Health Record

Diabetes is a significant medical problem in the United States and across the world. Despite significant progress in understanding how to better manage diabetes, there is oftentimes still ...

CT-controlled Advanced Navigation Techniques for Transbronchial Pulmonary Lesion Access; Evaluation of Augmented Fluoroscopy Based Virtual Bronchoscopic Navigation Diagnostic Yield

In this adaptive clinical trial we will investigate the diagnostic yield of a combination of commercially available imaging and navigation techniques for reaching peripheral lung lesions. ...

Companies [28 Associated Companies listed on BioPortfolio]

Hitachi, Ltd.

Hitachi, Ltd., (NYSE: HIT / TSE: 6501), headquartered in Tokyo, Japan, is a leading global electronics company with approximately 360,000 employees worldwide. Fiscal 2009 (ended M...

Hitachi Aloka Medical America, Inc.

Hitachi Aloka Medical America, Inc. is committed to delivering advanced diagnostic ultrasound systems and solutions to meet the needs of physicians and patients. With its U.S. and...

Hitachi Chemical Research Center, Inc

Beginning April 1, 2005, Hitachi Chemical Research Center, Inc., the parent company of RNAture, will handle all matters related to RNAture, Inc. products. All purchase requests or technical inquiries ...

Hitachi Data Systems Corporation

Hitachi Data Systems provides best-in-class information technologies, services and solutions that deliver compelling customer ROI, unmatched return on assets (ROA) and demonstrabl...

Hitachi Medical Systems America, Inc.

Hitachi Medical Systems America Inc. (HMSA) markets advanced diagnostic medical imaging systems of Hitachi Medical Corp., Tokyo, Japan. The company has more than 1,500 MRI systems...

More Information about "Hitachi, Ltd." on BioPortfolio

We have published hundreds of Hitachi, Ltd. news stories on BioPortfolio along with dozens of Hitachi, Ltd. Clinical Trials and PubMed Articles about Hitachi, Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hitachi, Ltd. Companies in our database. You can also find out about relevant Hitachi, Ltd. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record